Xflot
Foreign investors put a net $8.9 billion into Indian shares so far in NovemberAirTrunk signs ₹1.03 lakh crore plan for 1,400 MW of data centres in Andhra PradeshCoal India files to sell 66.18 crore Mahanadi Coalfields shares in an IPO due to open on 19 NovemberGrasim swings to a ₹234 crore Q2 loss after a ₹767 crore charge on its Canadian pulp ventureIndia's goods exports hit a record $49.47 billion in October as the goods deficit widens to $39.88 billionRupee ends at 94.20 a dollar as the US 10-year yield climbs above 5.1%Tata Motors PV posts ₹5,531 crore Q2 loss as JLR cuts its margin guidanceUS tells India its goods will get a tariff edge over rivals once Section 301 probes endIndia's retail inflation rises to 6.09% in October, above the RBI's 6% upper limitBrent drops below $90, about 25% under its late-October peak
Nifty 50 25,144.3 −0.61%Nifty Bank 61,034.1 −0.79%Nifty Midcap 150 22,681.25 −0.35%Nifty Smallcap 250 17,940.55 −0.30%Nifty IT 31,931.15 −0.72%India VIX 15.78 −5.06%NSE indices →

Jubilant Pharmova Ltd. JUBLPHARMA

NSE · Healthcare · updated 17 Nov 2026, 4:52 pm IST

AI summary5 points
Read all 5 points
  • Volume was light at 0.5× the 20-session average, with 32% taken as delivery against an average of 46%.
  • It is a NIFTY MICROCAP 250 constituent in the Healthcare industry.
  • No bulk or block deals were disclosed in 30 days and no promoter or insider trades in 90 days.

Written by Claude from this page's own figures at 15 Nov, 06:05 am IST — every number checked against the page. A summary, not advice.

AI summary
  1. Jubilant Pharmova closed at ₹964.1 on 13 Nov 2026, -1.92% on the day and 23.6% below its 52-week high.
  2. The 52-week range is ₹807.65 to ₹1,262.6; the stock is +2.7% over a month and +9.5% over three months.
  3. Volume was light at 0.5× the 20-session average, with 32% taken as delivery against an average of 46%.
  4. It is a NIFTY MICROCAP 250 constituent in the Healthcare industry.
  5. No bulk or block deals were disclosed in 30 days and no promoter or insider trades in 90 days.

Written by Claude from this page's own figures at 15 Nov, 06:05 am IST — every number checked against the page. A summary, not advice.

Last price
₹960.25
Change
-0.40%
Volume
2,82,886
vs avg volume
2.86x

Healthcare · MICROCAP · in NIFTY MICROCAP 250 · sector page

At a glance

Jubilant Pharmova Ltd. trades on the NSE under the symbol JUBLPHARMA and is classified under Healthcare (microcap cap by NSE's index grouping). It is a constituent of NIFTY MICROCAP 250. NSE's securities master records its listing date as 16 Jun 2003.

On 16 Nov 2026 the stock closed at ₹960.25, -0.4% on the day. Over the past year it has traded between ₹807.65 and ₹1,262.6; the current price sits 34% of the way up that range, 23.9% below the 52-week high. The move has been -0.6% over five sessions, +2.6% over a month, +6.4% over three months, -2.8% over six months.

Volume in the last session was 2.9× the stock's 20-session average — unusually heavy. 40% of that volume was taken as delivery, against a 20-session average of 45%. Delivery has fallen from about 49% to 44% over the last month.

No promoter or insider trades have been filed for the stock in the last 90 days. No bulk or block deals were disclosed in the last 30 days.

Among 13 Healthcare stocks tracked here, its one-month return ranks 13th; the strongest over the month was Sai Life Sciences Ltd. (+29.0%).

Face value₹1
ISININE700A01033
52-week range₹807.65 – ₹1,262.6
1-month return+2.6%
3-month return+6.4%
6-month return-2.8%
Delivery (last session)40% (avg 45%)
Insider filings (90d)0 buy / 0 sell
Disclosed deals (30d)0 buy / 0 sell

Peers in Healthcare

Piramal Pharma Ltd. +26.0% · Max Healthcare Institute Ltd. +21.7% · Sun Pharma Advanced Research Company Ltd. +5.8% · Biocon Ltd. +6.5% · Aarti Drugs Ltd. +25.5% · Laurus Labs Ltd. +7.3% · Viyash Scientific Ltd. +6.9% · Syngene International Ltd. +11.0% · Sun Pharmaceutical Industries Ltd. +7.1% · Sai Life Sciences Ltd. +29.0% · all Healthcare stocks

Business news touching this company or its sector

All business impact stories

Price and delivery

30d90d180dMax 250 sessions from 02 Dec 2025

Close price

Delivery % · 30-session average 50.7%

Delivery is the share of traded volume actually settled into demat accounts rather than squared off intraday — the difference between accumulation and churn. How it is used.

Bulk & block deals

Exchange-disclosed transactions, reported as published.

DateClientTypeQty PriceValue
12 Oct 2026ABAKKUS FOUR2EIGHT OPPORTUNITIES FUND BUY 11,00,000 ₹915 ₹100.65 Cr
12 Oct 2026QUANT MUTUAL FUND SELL 11,00,000 ₹915 ₹100.65 Cr

Latest news

Business Upturn · 13 Nov 2026
Jubilant Pharmova Q2 results: Net profit plunges 74% YoY to Rs 31.2 crore, revenue up 20.5%
Read at Business Upturn →

Free · one email a day

Market briefs, by country

Pick the markets you follow. Each morning: what changed, in figures — never a tip.

Markets

Free. We email a link to confirm — nothing is sent until you click it. Every brief has a one-click unsubscribe that deletes your record. Data, not advice: XDQ Labs is not registered with SEBI, the US SEC, FINRA or any European regulator. GMP is unofficial. Privacy. Sent daily at 08:15 India time.